Sorafenib

5mg

Cat. No.: 13-D24

$99.00

Sorafenib, also known as Nexavar, is a small molecule inhibitor of several tyrosine protein kinases, VEGFR 2 & 3 as well as PDGFR, and RAF/MEK/ERK cascade inhibitor. It also inhibits c-Kit, the ligand for Stem cell factor. It does not significantly inhibit MEK-1 or ERK-1 activity. It interacts in combination with the proteasome inhibitor bortezomib to induce apoptosis in a broad spectrum of neoplastic cell lines.

NOTE: The small molecule Sorafenib sold by Reagents Direct is NOT Nexavar®, and is NOT for human use.

Categories: ,

Details

TECHNICAL INFORMATION

Other Names: 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamine

Chemical Formula: C14H16CIF3N4O3

CAS Number: 284461-73-0

Molecular Weight: 464.82

Purity: >99%

IC50= 6nM

Appearance: Light Yellow Powder

Solubility: DMSO (100mM)

 

STORAGE AND HANDLING

Storage: Store at 4°C and protected from light. Following reconstitution, store  aliquots at -20°C. 

Stability: Stock solutions stable at -20°C for up to 2 years.

Shipping Conditions: Shipped at room temperature.

 

PRODUCT USE

Soluble in DMSO. Soluble at 20mg/ml

References

Bruix | J. | et al. (2012). Efficacy and Safety of Sorafenib in Patients with Advanced Hepatocellular Carcinoma: Subanalyses of a Phase III Trial. J Hepatol. 48:1452-65.

Gulhati | P. | et al. (2012). Sorafenib Enhances the Therapeutic Efficacy of Rapamycin in Colorectal Cancers Harboring Oncogenic Kras and PIK3CA. Carcinogenesis. 859:323-6556.

Zauli. G. | et al. (2012). The Sorafenib plus Nutlin-3 Combination Promotes Synergistic Cytotoxicity in Acute Myeloid Leukemic Cells Irrespectively of the FLT3 and p53 Status. Haematologica. 10:3324.

Tech Docs

Product Specifications

MSDS

Related products